Stockscreener 앱 받기
17.67
0.17%
-0.03
전일 마감가:
$17.70
열려 있는:
$17.75
하루 거래량:
128.04K
Relative Volume:
0.69
시가총액:
$1.19B
수익:
$-9,000
순이익/손실:
$-68.03M
주가수익비율:
-16.83
EPS:
-1.05
순현금흐름:
$-44.76M
1주 성능:
+8.60%
1개월 성능:
+3.64%
6개월 성능:
+9.96%
1년 성능:
+3.09%
1일 변동 폭
$17.45
$18.11
1주일 범위
$16.27
$18.66
52주 변동 폭
$13.77
$25.00
펄스 바이오 Stock (PLSE) Company Profile
명칭
Pulse Biosciences Inc
전화
510-906-4600
주소
3957 POINT EDEN WAY, HAYWARD, CA
PLSE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
17.67 | 1.19B | -9,000 | -68.03M | -44.76M | -1.05 |
|
ISRG
Intuitive Surgical Inc
|
443.99 | 160.51B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
186.05 | 53.46B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
274.19 | 40.35B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
75.00 | 37.18B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
259.94 | 18.03B | 2.96B | 487.70M | 344.00M | 6.68 |
펄스 바이오 Stock (PLSE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 개시 | Oppenheimer | Outperform |
| 2021-07-27 | 개시 | Stephens | Overweight |
| 2021-03-11 | 개시 | Maxim Group | Buy |
| 2021-01-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-12 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | 개시 | H.C. Wainwright | Buy |
모두보기
펄스 바이오 주식(PLSE)의 최신 뉴스
17,800 Shares in Pulse Biosciences, Inc $PLSE Purchased by Strs Ohio - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Shares Up 9.8%Still a Buy? - MarketBeat
Kevin Patrick Danahy Sells 20,000 Shares of Pulse Biosciences (NASDAQ:PLSE) Stock - MarketBeat
Pulse Biosciences CCO Danahy sells $377k in shares By Investing.com - Investing.com Canada
Pulse Biosciences (NASDAQ:PLSE) CTO Darrin Uecker Sells 20,000 Shares - MarketBeat
What does recent volatility data suggest for Pulse Biosciences Inc.2025 Earnings Surprises & Fast Momentum Entry Tips - newser.com
Using Ichimoku Cloud for Pulse Biosciences Inc. technicalsBear Alert & Momentum Based Trading Ideas - newser.com
Pulse Biosciences (NASDAQ:PLSE) CTO Darrin Uecker Sells 25,000 Shares - MarketBeat
Patterns Watch: Is Pulse Biosciences Inc stock a good pick for beginnersTrade Volume Summary & Intraday High Probability Setup Alerts - khodrobank.com
Is Pulse Biosciences Inc stock a good pick for beginnersRecession Risk & AI Forecast for Swing Trade Picks - khodrobank.com
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up After Insider Buying Activity - MarketBeat
Breakouts Watch: Is Pulse Biosciences Inc vulnerable to short sellers2025 Volatility Report & Daily Entry Point Trade Alerts - خودرو بانک
Using Bollinger Bands to evaluate Pulse Biosciences Inc.2025 Earnings Surprises & Stepwise Trade Signal Guides - newser.com
Can technical indicators confirm Pulse Biosciences Inc.’s reversalJuly 2025 PreEarnings & AI Enhanced Trade Execution Alerts - newser.com
Market reaction to Pulse Biosciences Inc.’s recent newsWall Street Watch & Long-Term Capital Growth Ideas - newser.com
Will Pulse Biosciences Inc. continue its uptrend2025 Retail Activity & Free Daily Entry Point Trade Alerts - newser.com
Pulse Biosciences (PLSE) CTO Uecker sells $731,200 in shares By Investing.com - Investing.com Canada
Pulse Biosciences (PLSE) CTO Uecker sells $731,200 in shares - Investing.com
Pulse Biosciences Breaks Above 200-Day Moving AverageBullish for PLSE - Nasdaq
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 17, 2025 - BioSpace
Pulse Biosciences announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Using economic indicators to assess Pulse Biosciences Inc. potential2025 Retail Activity & Stepwise Trade Execution Plans - newser.com
Pulse Biosciences (NASDAQ:PLSE) Shares Down 6.4%What's Next? - MarketBeat
Risk Hedge: Is Pulse Biosciences Inc stock influenced by commodity prices2025 Retail Activity & Low Risk High Win Rate Stock Picks - خودرو بانک
Momentum Shift: Is Pulse Biosciences Inc benefiting from innovation trendsProfit Target & Weekly Return Optimization Alerts - خودرو بانک
Momentum Shift: Should you buy the dip on Bowman Consulting Group LtdStop Loss & Daily Growth Stock Investment Tips - خودرو بانک
Breakout Move: Is Pulse Biosciences Inc benefiting from innovation trendsMarket Performance Summary & Weekly High Conviction Trade Ideas - خودرو بانک
Institution Moves: Whats the outlook for Pulse Biosciences Incs sectorJuly 2025 WrapUp & Reliable Intraday Trade Plans - خودرو بانک
Retail Trends: Can Pulse Biosciences Inc. withstand a market correction2025 Analyst Calls & Smart Investment Allocation Tips - خودرو بانک
Retail Surge: Is Pulse Biosciences Inc affected by consumer sentimentJuly 2025 Recap & Community Verified Swing Trade Signals - خودرو بانک
Pulse Biosciences Reports Q2 2025 Progress and Results - MSN
Aug Movers: Is Pulse Biosciences Inc forming a breakout pattern2025 Price Momentum & Verified High Yield Trade Plans - خودرو بانک
Sectors Review: Can Pulse Biosciences Inc continue delivering strong returnsBreakout Watch & Growth Oriented Trade Recommendations - خودرو بانک
Rate Hike: Can Pulse Biosciences Inc continue delivering strong returnsWeekly Loss Report & Reliable Price Action Trade Plans - khodrobank.com
Pulse Biosciences, Inc $PLSE Stock Position Lowered by Inspire Investing LLC - Defense World
How to recover losses in Pulse Biosciences Inc. stockJuly 2025 Summary & Weekly Stock Performance Updates - newser.com
can technical indicators confirm pulse biosciences inc.’s reversal2025 AllTime Highs & Advanced Swing Trade Entry Alerts - newser.com
Pulse Biosciences Stock (PLSE) Opinions on FDA IDE Approval - Quiver Quantitative
Pulse Biosciences Director Robert W Duggan Acquires Shares - TradingView
Combining machine learning predictions for Pulse Biosciences Inc.CPI Data & Weekly Setup with High ROI Potential - Newser
Pulse Biosciences (PLSE) director Duggan buys shares worth $2.79 million By Investing.com - Investing.com Nigeria
Pulse Biosciences (PLSE) director Duggan buys shares worth $2.79 million - Investing.com
펄스 바이오 (PLSE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
1.26%
자본화:
|
볼륨(24시간):